Cargando…
Clinical Evidence for Variegated Silencing in Patients With Friedreich Ataxia
BACKGROUND AND OBJECTIVES: Friedreich ataxia (FRDA) is a neurodegenerative disease caused by a GAA triplet repeat (GAA-TR) expansion in intron 1 of the FXN gene. Patients have 100–1,300 GAA triplets compared with less than 30 in healthy controls. The GAA-TR expansion leads to FXN silencing, and cons...
Autores principales: | Rodden, Layne N., Rummey, Christian, Dong, Yi Na, Lynch, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128033/ https://www.ncbi.nlm.nih.gov/pubmed/35620135 http://dx.doi.org/10.1212/NXG.0000000000000683 |
Ejemplares similares
-
Methylated and unmethylated epialleles support variegated epigenetic silencing in Friedreich ataxia
por: Rodden, Layne N, et al.
Publicado: (2021) -
Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxia
por: Rodden, Layne N., et al.
Publicado: (2023) -
DNA methylation in Friedreich ataxia silences expression of frataxin isoform E
por: Rodden, Layne N., et al.
Publicado: (2022) -
Predictors of loss of ambulation in Friedreich's ataxia
por: Rummey, Christian, et al.
Publicado: (2020) -
SARS-CoV-2 in patients with Friedreich ataxia
por: Shen, Megan M., et al.
Publicado: (2022)